AI Medical receives CE mark for Jazz automation software

AI Medical has received the CE marking following the European Union Medical Device Regulation (MDR) for its intelligent automation software Jazz.

Jazz is an artificial intelligence (AI) platform that is designed to assist healthcare professionals in making accurate and timely medical diagnoses. The product supports radiologists in producing reports, by automating low-level tasks, such as lesion annotation, anatomical lesion position detection, and lesion volume measurement. Jazz can be used for complex follow-up assessment of chronic diseases with magnetic resonance imaging, such as multiple sclerosis and brain metastasis.

CEO Christian Federau said: "We are thrilled to receive the CE marking for Jazz, which is a testament to the hard work and dedication of our team, as well as the quality of our products. Our goal has always been to make a positive impact on the healthcare industry and help improve patient outcomes. With the CE marking, we are one step closer to achieving that goal and bringing our innovative AI technology to the global market."